Suppr超能文献

中性粒细胞从循环系统到气腔的迁移的调控机制。

Regulatory mechanisms of neutrophil migration from the circulation to the airspace.

机构信息

Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, NIH, 111 T.W. Alexander Drive, P.O. Box 12233, MD D2-01, Research Triangle Park, NC, 27709, USA.

出版信息

Cell Mol Life Sci. 2021 May;78(9):4095-4124. doi: 10.1007/s00018-021-03768-z. Epub 2021 Feb 5.

Abstract

The neutrophil, a short-lived effector leukocyte of the innate immune system best known for its proteases and other degradative cargo, has unique, reciprocal physiological interactions with the lung. During health, large numbers of 'marginated' neutrophils reside within the pulmonary vasculature, where they patrol the endothelial surface for pathogens and complete their life cycle. Upon respiratory infection, rapid and sustained recruitment of neutrophils through the endothelial barrier, across the extravascular pulmonary interstitium, and again through the respiratory epithelium into the airspace lumen, is required for pathogen killing. Overexuberant neutrophil trafficking to the lung, however, causes bystander tissue injury and underlies several acute and chronic lung diseases. Due in part to the unique architecture of the lung's capillary network, the neutrophil follows a microanatomic passage into the distal airspace unlike that observed in other end-organs that it infiltrates. Several of the regulatory mechanisms underlying the stepwise recruitment of circulating neutrophils to the infected lung have been defined over the past few decades; however, fundamental questions remain. In this article, we provide an updated review and perspective on emerging roles for the neutrophil in lung biology, on the molecular mechanisms that control the trafficking of neutrophils to the lung, and on past and ongoing efforts to design therapeutics to intervene upon pulmonary neutrophilia in lung disease.

摘要

中性粒细胞是先天免疫系统中一种寿命较短的效应白细胞,以其蛋白酶和其他降解货物而闻名,它与肺部有独特的、相互的生理相互作用。在健康状态下,大量“边缘”中性粒细胞驻留在肺血管中,在那里它们巡逻内皮表面以寻找病原体并完成其生命周期。在呼吸道感染时,需要通过内皮屏障、穿过血管外肺间质、再次穿过呼吸上皮细胞进入肺泡腔,快速和持续地招募中性粒细胞,以杀死病原体。然而,中性粒细胞过度活跃地迁移到肺部会导致旁观者组织损伤,并导致几种急性和慢性肺部疾病。部分由于肺毛细血管网络的独特结构,中性粒细胞遵循微解剖通道进入远端气腔,与它浸润的其他终末器官观察到的不同。在过去几十年中,已经定义了几个控制循环中性粒细胞逐步招募到感染肺部的调节机制;然而,仍存在一些基本问题。在本文中,我们提供了对中性粒细胞在肺生物学中作用的最新综述和观点,以及控制中性粒细胞向肺部迁移的分子机制,以及过去和正在进行的努力,以设计治疗方法来干预肺部中性粒细胞增多症在肺部疾病中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4711/11073353/4377b46ea909/18_2021_3768_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验